Intelligence desk

Products

Signal Tracker Data Platform Data Enrichment API

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Altris AI logo — AI Decision Support for OCT Analysis that elevates Ophthalmo...

Altris AI

AI Decision Support for OCT Analysis that elevates Ophthalmology, Research, and Optometry.

Founded 2018 United States Chicago, United States 33 employees Seed Total: $1.00M AI, Biotechnology +4

General Information

Company Name Altris AI
Founded Year 2018
Location United States Chicago, United States +1
Employees 33
Industries AI, Biotechnology, Education +3
Funding Stage Seed
Social

Get notified when Altris AI moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Altris AI

Altris AI, founded in 2018, is a cutting-edge web platform specializing in the analysis of OCT scans using artificial intelligence. This innovative tool distinguishes itself by detecting over 70 retina pathologies, including rare conditions, ensuring both an expedited and more precise OCT examination process.

The company's offering is particularly appealing due to its compliance with GDPR standards, ensuring encrypted and secure data management with forthcoming FDA clearance. Enhanced accuracy and diagnostic speed have led to its adoption in over 30 eye clinics and optometry centers worldwide.

Based in the United States, Altris AI operates within diverse industries, including AI, Biotechnology, and Health Care. The company recently received investment from Network. VC during a funding round on August 14, 2023. This investment underscores its potential for significant growth in the burgeoning AI-driven healthcare segment.

Taxonomy: algorithm, OCT scan analysis, retina pathologies, diagnostic tool, data encryption, GDPR compliance, CE certificate, FDA clearance, optometry centers, medical imaging, digital health

Services & Products

AI Enhanced OCT Scan Analysis
Early Disease Detection
Quantitative Biomarker Measurements
Clinical Decision Support
Historical Data Analysis

Target Customers

Ophthalmologists Optometrists Ophthalmic Clinics Research Institutions Optometry Clinics Eye Care Specialists

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Unknown 1
SID Venture Partners
01 Jan 2025
Unknown Unknown 1 Network VC 01 Aug 2023
Seed $1.00M 7
Brinc Runa Capital The University of Chicago JOINT JOURNEY
Artesian Capital Management, Chicago Booth Angels Network of London +1 		01 Dec 2022
Seed Unknown 1
Brinc
01 Jul 2021

Altris AI Alternatives & Competitors

Altris AI vs
Cylite
Cylite Australia

HP-OCT® The next generation OCT empowering Ophthalmology and Optometry Hyperparallel OCT technology

Series B
86 employees
Medical Devices
Compare Altris AI vs Cylite
Altris AI vs
IlluminOss Medical Inc.
IlluminOss Medical Inc. United States

World's first patient-conforming intramedullary implant using balloons, light activated monomers and...

Series Unknown
35 employees
Health Care, Manufacturing
Compare Altris AI vs IlluminOss Medical Inc.
Altris AI vs
VitalSigns Oy
VitalSigns Oy Finland

Rethinking physical examination in medical practice.

Seed
8 employees
Compare Altris AI vs VitalSigns Oy

FAQ About Altris AI

AI Decision Support for OCT Analysis that elevates Ophthalmology, Research, and Optometry.
Altris AI was founded in 2018.
Altris AI is headquartered in Chicago, United States.
Altris AI operates in the following industries: AI, Biotechnology, Education, Health Care, Mobile, Machine Learning.
Altris AI has approximately 33 employees.
Altris AI has completed 4 funding rounds, raising a total of $1.00M. The latest funding stage is Seed.
Altris AI offers: AI Enhanced OCT Scan Analysis, Early Disease Detection, Quantitative Biomarker Measurements, Clinical Decision Support, Historical Data Analysis.
Top alternatives and competitors to Altris AI include Cylite, IlluminOss Medical Inc., VitalSigns Oy, Damae Medical, MedAssure Services. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Altris AI and Cylite are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Altris AI and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy